Psychometric Properties of the Persian Version of Screening for Somatic Symptom Disorders-7(SOMS-7)

• Main Authors: Amrollah Ebrahimi, Winfried Rief, Peyman Mirshahzadeh, Hamid Afshar zanjani, Hamid Nasiri Dehsorkhi, Hamidreza Roohafza, Awat Feizi, Peyman Adibi
• Format: Article
• Language: English
• Published: Tehran University of Medical Sciences 2018-08-01
• Series: Iranian Journal of Psychiatry
• Subjects: Persian Version; Reliability; Screening for Somatic Symptom Disorders; SOMS-7; Validity
• Online Access: https://ijps.tums.ac.ir/index.php/ijps/article/view/1075

Objective: Somatic symptoms are one of the most prevalent complaints in both psychiatric and general population, and validated scales are required to assess these problems. The present study was conducted to determine psychometric properties of the Persian version of Screening for Somatic Symptom Disorders-7(SOMS-7) in an Iranian population. Method: This was a multi centric comprehensive study conducted in Psychosomatic Research Center of Isfahan University of Medical Sciences in collaboration with Department of Clinical Psychology of Philipp University of Marburg, Germany. This part of the study includes 100 patients with anxiety/mood disorders and 291 healthy individuals. All participants completed the Patient Health Questionnaire (PHQ-15) and Screening for Somatic symptom disorders 7(SOMS-7). Data were analyzed by Pearson and Spearman correlation coefficient, factor analysis, independent t test, and discriminant analysis using SPSS-20 software. Results: Reliability coefficient based on Cronbach’s alpha was 0.92 and 0.94 (clinical vs. healthy sample). Validity index of the SOMS according to correlation between factor 1 and 2 with PHQ somatic subscale was. 51 and. 59, respectively. Score of 15.5 as cut-off point was accompanied with sensitivity of 77% and specificity of 66%. Factor analysis extracted 2 factors in patients and 4 factors in healthy population. Conclusion: Findings of this study indicated that the Persian version of SOMS-7 has appropriate reliability and validity for the assessment of somatic symptoms disorder and evaluation of treatment effects in these patients.